Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Medesis Pharma and CEA sign collaborative agreement

April 3, 2014

Southwest Research Institute receives contract extension for cyanide antidote

March 31, 2014

New monoclonal antibodies for the treatment of botulism disclosed

March 24, 2014

MediciNova announces start of MN-166 clinical study for marijuana dependence

March 11, 2014

Titan Pharmaceuticals and FDA discuss path forward for Probuphine

March 4, 2014

Humanetics and USAMRICD enter into CRADA to study BIO-300 to treat phosgene exposure

Feb. 26, 2014

FDA clears path for smoking cessation trial of INV-102

Jan. 30, 2014

Phase I study of novel treatment candidate for alcoholism begins patient recruitment

Jan. 27, 2014

FDA grants orphan drug status to Aeolus' drug candidate for treatment of acute radiation syndrome

Jan. 24, 2014

Neumedicines' HemaMax shown to improve survival outcomes following lethal irradiation

Jan. 10, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...